RecruitingNot ApplicableNCT04766216

Warfarin Patient Self-management Implementation in the US Healthcare System

Overcoming Barriers to Warfarin Patient Self-management Implementation in the US Healthcare System

Sponsor

University of Utah

Enrollment

150 participants

Start Date

Mar 15, 2023

Study Type

INTERVENTIONAL

Conditions

Atrial Fibrillation Venous Thromboembolism Heart Valve Diseases

Summary

In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a structured program for warfarin self-management — where patients test their own blood clotting levels at home and adjust their warfarin dose themselves — can be successfully implemented in U.S. healthcare settings. **You may be eligible if...** - You are 18 years or older - You have been taking warfarin for at least 9 months for any reason - You are able and willing to test your own INR (blood clotting level) using a home device or same-day clinic results - You are willing to make independent decisions about adjusting your warfarin dose based on results - You can test your INR at least every 2 weeks **You may NOT be eligible if...** - You have been on warfarin for less than 9 months - You are unable or unwilling to self-test your INR - You are not comfortable making dosing decisions independently Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.